Five-Year Outcomes: Laparoscopic Greater Curvature Plication for Treatment of Morbid Obesity
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články
PubMed
28560523
DOI
10.1007/s11695-017-2709-3
PII: 10.1007/s11695-017-2709-3
Knihovny.cz E-zdroje
- Klíčová slova
- Diabetes, LGCP, Laparoscopic greater curvature plication, Obesity,
- MeSH
- bariatrická chirurgie škodlivé účinky metody statistika a číselné údaje MeSH
- délka operace MeSH
- diabetes mellitus 2. typu epidemiologie chirurgie MeSH
- dospělí MeSH
- gastrektomie metody MeSH
- hmotnostní úbytek MeSH
- index tělesné hmotnosti MeSH
- laparoskopie škodlivé účinky metody statistika a číselné údaje MeSH
- lidé středního věku MeSH
- lidé MeSH
- morbidní obezita epidemiologie chirurgie MeSH
- následné studie MeSH
- pooperační komplikace epidemiologie etiologie MeSH
- reoperace statistika a číselné údaje MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Laparoscopic greater curvature plication (LGCP) is a newer metabolic/bariatric surgical procedure that requires no resection, bypass, or implantable device. We report outcomes in a cohort of LGCP patients at 5-year follow-up. METHODS: Body mass index (BMI, kg/m2) evolution, excess weight loss (%EWL), excess BMI loss (%EBMIL), and total weight loss (%TWL) were recorded. Repeated measures analysis of variance (ANOVA) was used to assess BMI change over 5 years. Two-step cluster analysis was used to profile LGCP patients according to significant characteristics relative to successful 5-year weight loss. RESULTS: Of patients entering the study between 2010 and 2011 with complete weight data through 5-year follow-up (86.9%, 212/244), mean age was 45.8 ± 10.9 years; mean baseline BMI, 41.4 ± 5.5 (81.6% women); 58 patients (27.4%) had type 2 diabetes. Mean operative time was 69.0 min; mean hospitalization, 38 h (24-72). ANOVA indicated a significant BMI reduction out to 2 years (p < 0.001), a plateau at 3 and 4 years, and a moderate but significant BMI increase at 5 years (p < 0.01). EBMIL at 1, 2, 3, 4, and 5 years was as follows: 50.7 ± 9.1%, 61.5 ± 8.1%, 60.2 ± 7.0%, 58.5 ± 7.0%, and 56.8 ± 6.3%. At 5 years, 79.2% (168/212) of patients were successful; 20.8% (44/212) experienced a suboptimal weight outcome; mean weight regain, 9.2%. Cluster analysis identified four distinct LGCP patient profiles. Diabetes improvement rate was 65.5%. There were 12 reoperations (4.9%): 4 emergency (1.6%) and 8 (3.3%) elective. There was no mortality. CONCLUSIONS: At 5-year follow-up, LGCP proved to be safe and effective, with 56.8% EBMIL and a low rate of complications.
1st Faculty of Medicine Charles University Prague Czech Republic
Division of Scientific Research Writing Medwrite Medical Communications Maiden Rock WI USA
OB Klinika a s Pod Krejcarkem 975 130 00 Prague 3 Czech Republic
Statistical Analysis and Quality of Life Assessment McGlennon MotiMetrics Maiden Rock WI USA
Zobrazit více v PubMed
Surg Obes Relat Dis. 2012 Nov-Dec;8(6):e77-9 PubMed
Stat Bull Metrop Life Found. 1983 Jan-Jun;64(1):3-9 PubMed
Surg Obes Relat Dis. 2014 Mar-Apr;10(2):243-9 PubMed
Surg Obes Relat Dis. 2008 Sep-Oct;4(5 Suppl):S109-84 PubMed
Obes Surg. 2002 Oct;12(5):705-17 PubMed
Lancet. 2012 Jun 16;379(9833):2300-11 PubMed
Obes Surg. 2007 May;17(5):565-8 PubMed
Ann R Coll Surg Engl. 2012 Mar;94(2):e76-8 PubMed
Obes Surg. 2012 Oct;22(10):1629-32 PubMed
Cir Esp. 2011 Jun-Jul;89(6):356-61 PubMed
J Clin Invest. 2007 Jan;117(1):13-23 PubMed
Ann Surg Innov Res. 2012 Aug 22;6(1):7 PubMed
Int J Obes (Lond). 2007 Aug;31(8):1248-61 PubMed
Surg Obes Relat Dis. 2015 Sep-Oct;11(5):1004-7 PubMed
J Laparoendosc Adv Surg Tech A. 2007 Dec;17(6):793-8 PubMed
Obes Surg. 2013 Feb;23(2):179-83 PubMed
Obes Surg. 2011 Jun;21(6):763-7 PubMed
JAMA Surg. 2015 Nov;150(11):1051-7 PubMed
Obes Surg. 2013 Apr;23(4):446-55 PubMed
Surg Obes Relat Dis. 2015 May-Jun;11(3):518-24 PubMed
Ann Intern Med. 1991 Dec 15;115(12):956-61 PubMed
Surg Obes Relat Dis. 2014 Nov-Dec;10(6):1226-32 PubMed
Surg Obes Relat Dis. 2012 Nov-Dec;8(6):e80-1 PubMed
Obes Surg. 2013 Sep;23(9):1397-403 PubMed
JAMA. 2004 Oct 13;292(14):1724-37 PubMed
Obes Surg. 2013 Jan;23(1):87-92 PubMed
Obes Surg. 2010 Jul;20(7):913-8 PubMed
Obes Surg. 2012 Aug;22(8):1298-307 PubMed
Obes Surg. 2014 Mar;24(3):437-55 PubMed
Obesity (Silver Spring). 2007 May;15(5):1187-98 PubMed
Surg Obes Relat Dis. 2014 Jan-Feb;10(1):177-83 PubMed
Surg Obes Relat Dis. 2011 Jan-Feb;7(1):15-22 PubMed
Minim Invasive Surg. 2012;2012:696348 PubMed
Obes Surg. 2004 Feb;14(2):160-4 PubMed
Obes Surg. 2011 Nov;21(11):1657-63 PubMed
Obes Surg. 2014 May;24(5):718-26 PubMed
Surg Obes Relat Dis. 2015 Nov-Dec;11(6):1199-200 PubMed
J Kans Med Soc. 1976 Nov;77(11):488-90 PubMed
Am J Med. 2009 Mar;122(3):248-256.e5 PubMed
Surg Endosc. 2013 Aug;27(8):2768-74 PubMed
Surg Obes Relat Dis. 2014 May-Jun;10(3):396-403 PubMed
Obes Surg. 2006 Aug;16(8):1032-40 PubMed
N Engl J Med. 2012 Apr 26;366(17):1567-76 PubMed
